⏳ Fetching live dividend data...
Home › Calculator › NUVA Dividend Calculator 2026
NuVasive, Inc. · NASDAQ
Price: $39.75 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in NUVA → $21.3K in 10 years · $60.99/month
NuVasive, Inc. is a medical technology firm focused on creating, producing, and distributing comprehensive procedural solutions for spinal operations. The company offers a range of surgical access instruments, such as the Maxcess integrated split-blade retractor system, which facilitates less-invasive surgical approaches by significantly reducing soft tissue disruption during spinal procedures. Additionally, NuVasive manufactures specialized spinal implants designed to improve spinal fusion by optimizing the osseointegration and biomechanical characteristics of materials like porous titanium and porous polyetheretherketone. Its fixation systems are engineered to help maintain and re-establish proper patient alignment. Other offerings include cervical total disc replacement technology, used in cervical spinal fusion surgery, and advanced neuromonitoring systems. These systems leverage proprietary software for nerve detection and avoidance, complemented by comprehensive intraoperative neuromonitoring services and support. The Pulse platform, a distinctive software ecosystem, unifies various hardware technologies into a compact, integrated system within the operating room environment. Furthermore, NuVasive supplies expandable growing rod implant systems for managing early-onset scoliosis, along with diverse biologics crucial for supporting spinal fusion or bone healing. Another key product is Precice, an intramedullary implant device that employs MAGEC technology for the non-invasive lengthening of the femur and tibia. The company also offers both onsite and remote monitoring solutions for the neurological systems of patients undergoing spinal and brain-related surgical interventions. NuVasive distributes its products to a broad client base, including patients, surgeons, hospitals, and insurers, through a multi-channel sales approach encompassing independent sales agents, its own sales force, and distributors, operating across the United States and global markets. Established in 1997, NuVasive, Inc. maintains its corporate headquarters in San Diego, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open NUVA position with:
Real after-tax yield depends on where you live and how you hold NUVA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 5.03% | 2.23% | $503 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 4.28% | 1.48% | $428 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 4.02% | 1.22% | $402 / yr |
| 🇬🇧 UK ISA | 0% | 5.03% | 2.23% | $503 / yr |
| 🇬🇧 UK Taxable | 8.75% | 4.59% | 1.79% | $459 / yr |
| 🇨🇦 TFSA | 0% | 5.03% | 2.23% | $503 / yr |
| 🇨🇦 CA Taxable | 25% | 3.77% | 0.97% | $377 / yr |
| 🇦🇺 Super (pension) | 15% | 4.28% | 1.48% | $428 / yr |
| 🇦🇺 AU Taxable | 30% | 3.52% | 0.72% | $352 / yr |
| 🇩🇪 DE Taxable | 26.375% | 3.70% | 0.90% | $370 / yr |
| 🇫🇷 FR Taxable | 30% | 3.52% | 0.72% | $352 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
NUVA pays quarterly — 4 times per year. Next ex-div: TBD.
How NUVA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NUVA sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| D-Return | 2023-09-01 | 4,816 | — | — | ||
| D-Return | 2023-09-01 | 4,816 | — | — | ||
| D-Return | 2023-09-01 | 3,095 | $0.00 | $3.00 | ||
| D-Return | 2023-09-01 | 4,816 | — | — | ||
| D-Return | 2023-09-01 | 4,816 | — | — | ||
| D-Return | 2023-09-01 | 3,739 | $0.00 | $4.00 | ||
| D-Return | 2023-09-01 | 4,816 | — | — | ||
| D-Return | 2023-09-01 | 1,360 | $0.00 | $1.00 | ||
| D-Return | 2023-09-01 | 4,816 | — | — | ||
| D-Return | 2023-09-01 | 3,788 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NUVA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
NuVasive, Inc. (NUVA) is currently trading at $39.75, trading near its 52-week low. The current dividend yield is 5.03% based on an annual payout of $2.00 per share.
NuVasive, Inc. (NUVA) is a healthcare stock currently trading at $39.75 with a dividend yield of 5.03%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →